(Q38003476)

26 August 2017

title

Potential avenues for immunotherapy of colitis-associated neoplasia (English)

1 reference

26 August 2017

1 reference

Maximilian J Waldner

1

1 reference

26 August 2017

Markus F Neurath

series ordinal

2

1 reference

26 August 2017

publication date

1 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

4

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

397-405

1 reference

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

26 August 2017

cites work

1 reference

Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

21 January 2018

1 reference

Cancer in Crohn's disease: dispelling the myths

21 January 2018

1 reference

Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis

21 January 2018

1 reference

Diagnosis and management of dysplasia in patients with inflammatory bowel diseases

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2010

1 reference

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

21 January 2018

1 reference

Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence

21 January 2018

1 reference

Progress and challenges in colorectal cancer screening and surveillance

21 January 2018

1 reference

Intestinal inflammation and cancer

21 January 2018

1 reference

Endoscopic and pathological aspects of colitis-associated dysplasia

21 January 2018

1 reference

Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

21 January 2018

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

Colorectal cancer molecular biology moves into clinical practice

21 January 2018

1 reference

Genomic and epigenetic instability in colorectal cancer pathogenesis

21 January 2018

1 reference

APC mutations occur early during colorectal tumorigenesis

21 January 2018

1 reference

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis

21 January 2018

1 reference

Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications

21 January 2018

1 reference

Molecular biology of dysplasia and cancer in inflammatory bowel disease

21 January 2018

1 reference

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

Inflammation and cancer: an ancient link with novel potentials.

21 January 2018

1 reference

Inflammatory Bowel Disease

21 January 2018

1 reference

Unravelling the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

New IBD genetics: common pathways with other diseases.

21 January 2018

1 reference

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

The contribution of endogenous sources of DNA damage to the multiple mutations in cancer

21 January 2018

1 reference

Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia

21 January 2018

1 reference

Altered expression of MUTYH and an increase in 8-hydroxydeoxyguanosine are early events in ulcerative colitis-associated carcinogenesis.

21 January 2018

1 reference

Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

Oxidative stress in ulcerative colitis-associated carcinogenesis

21 January 2018

1 reference

Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?

21 January 2018

1 reference

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

21 January 2018

1 reference

Aspirin and colon cancer--targeting prevention?

21 January 2018

1 reference

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

21 January 2018

1 reference

The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia

21 January 2018

1 reference

Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands

21 January 2018

1 reference

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

Differential TNF-signaling in chronic inflammatory disorders

21 January 2018

1 reference

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

21 January 2018

1 reference

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

21 January 2018

1 reference

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

21 January 2018

1 reference

Interleukin 6: from bench to bedside

21 January 2018

1 reference

Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer

21 January 2018

1 reference

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer

21 January 2018

1 reference

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

21 January 2018

1 reference

Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells.

21 January 2018

1 reference

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

21 January 2018

1 reference

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

21 January 2018

1 reference

VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer

21 January 2018

1 reference

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk

21 January 2018

1 reference

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

Predominant T helper type 2-inflammatory responses promote murine colon cancers

21 January 2018

1 reference

21 January 2018

IL-23/IL-17 axis in IBD.

1 reference

IL-23 promotes tumour incidence and growth

21 January 2018

1 reference

Th17 cells in cancer: help or hindrance?

21 January 2018

1 reference

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies

21 January 2018

1 reference

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

21 January 2018

1 reference

Colorectal cancer prevention in ulcerative colitis: a case-control study.

21 January 2018

1 reference

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.12.15

1 reference

26 August 2017

1 reference